Very Low-Molecular-Mass Fragments of Albumin in the Plasma of Patients With Focal Segmental Glomerulosclerosis

American Journal of Kidney Diseases

Volumn 54, Issue 5, 2009, Pages 871-880

  Hellin, Joan Lopez ^a   Bech Serra, Joan J ^b   Moctezuma, Enrique Lara ^b   Chocron, Sara ^b   Santin, Sheila ^c   Madrid, Alvaro ^b   Vilalta, Ramon ^b   Canals, Francesc ^b   Torra, Roser ^c   Meseguer, Anna ^a   Nieto, Jose L ^b  

^a Institut de Recerca   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c FUNDACIÓ PUIGVERT   (Spain)

Author keywords

albumin fragments; Focal segmental glomerulosclerosis; nephrotic syndrome; proteomics

Indexed keywords

ALBUMIN; CORTICOSTEROID; PLASMA PROTEIN; PROTEOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD SAMPLING; CARBOXY TERMINAL SEQUENCE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENETIC DISORDER; HUMAN; IDIOPATHIC DISEASE; LIQUID CHROMATOGRAPHY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEINURIA; SCHOOL CHILD; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MALE; MOLECULAR WEIGHT; MUTATION; PROTEOMICS; SERUM ALBUMIN;

EID: 70350130546     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.07.011     Document Type: Article

References (37)

1. Deegens J.K., Dijkman H.B., Borm G.F., et al. Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int 74 (2008) 1568-1576
2. Eddy A.A., and Symons J.M. Nephrotic syndrome in childhood. Lancet 362 (2003) 629-639
3. Cameron J.S. Focal segmental glomerulosclerosis in adults. Nephrol Dial Transplant 18 suppl 6 (2003) vi45-vi51
4. Kitiyakara C., Eggers P., and Kopp J.B. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 44 (2004) 815-825
5. Niaudet P. Genetic forms of nephrotic syndrome. Pediatr Nephrol 19 (2004) 1313-1318
6. Sharma M., Sharma R., McCarthy E.T., and Savin V.J. The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects. Exp Biol Med (Maywood) 229 (2004) 85-98
7. Daskalakis N., and Winn M.P. Focal and segmental glomerulosclerosis. Cell Mol Life Sci 63 (2006) 2506-2511
8. Carraro M., Zennaro C., Candiano G., et al. Nephrotic urine prevents increased rat glomerular albumin permeability induced by serum from the same patient with idiopathic nephrotic syndrome. Nephrol Dial Transplant 18 (2003) 689-693
9. Briggs J.D., and Jones E. Recurrence of glomerulonephritis following renal transplantation. Scientific Advisory Board of the ERA-EDTA Registry. European Renal Association-European Dialysis and Transplant Association. Nephrol Dial Transplant 14 (1999) 564-565
10. Crosson J.T. Focal segmental glomerulosclerosis and renal transplantation. Transplant Proc 39 (2007) 737-743
11. Caridi G., Perfumo F., and Ghiggeri G.M. NPHS2 (podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms. Pediatr Res 57 (2005) 54R-61R
12. Carraro M., Caridi G., Bruschi M., et al. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) and steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13 (2002) 1946-1952
13. Sharma M., Sharma R., McCarthy E.T., and Savin V.J. "The FSGS factor": enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J Am Soc Nephrol 10 (1999) 552-561
14. Le Berre L., Godfrin Y., Lafond-Puyet L., et al. Effect of plasma fractions from patients with focal and segmental glomerulosclerosis on rat proteinuria. Kidney Int 58 (2000) 2502-2511
15. Lopez-Hellin J., Gonzalo R., Tejeda M., et al. Transcriptomic and proteomic analysis of liver and muscle alterations caused by surgical stress in rat. Clin Sci (Lond) 108 (2005) 167-168
16. Schagger H. Tricine-SDS-PAGE. Nat Protoc 1 (2006) 16-22
17. Janech M.G., Raymond J.R., and Arthur J.M. Proteomics in renal research. Am J Physiol Renal Physiol 292 (2007) F501-F512
18. Thongboonkerd V., and Malasit P. Renal and urinary proteomics: current applications and challenges. Proteomics 5 (2005) 1033-1042
19. O'Riordan E., Gross S.S., and Goligorsky M.S. Technology insight: renal proteomics-at the crossroads between promise and problems. Nat Clin Pract Nephrol 2 (2006) 445-458
20. Gygi S.P., Corthals G.L., Zhang Y., Rochon Y., and Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci U S A 97 (2000) 9390-9395
21. Quero C., Colome N., Prieto M.R., et al. Determination of protein markers in human serum: analysis of protein expression in toxic oil syndrome studies. Proteomics 4 (2004) 303-315
22. Osicka T.M., and Comper W.D. Characterization of immunochemically nonreactive urinary albumin. Clin Chem 50 (2004) 2286-2291
23. Hilliard L.M., Osicka T.M., Clavant S.P., Robinson P.J., Nikolic-Paterson D.J., and Comper W.D. Characterization of the urinary albumin degradation pathway in the isolated perfused rat kidney. J Lab Clin Med 147 (2006) 36-44
24. Clavant S.P., Sastra S.A., Osicka T.M., and Comper W.D. The analysis and characterisation of immuno-unreactive urinary albumin in healthy volunteers. Clin Biochem 39 (2006) 143-151
25. Candiano C.B.M., Petretto A., Santucci L., et al. Proteins and protein fragments in nephrotic syndrome: clusters, specificity and mechanisms. Proteomics Clin Appl 2 (2008) 956-963
26. Candiano G., Musante L., Bruschi M., et al. Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. J Am Soc Nephrol 17 (2006) 3139-3148
27. Musante L., Bruschi M., Candiano G., et al. Characterization of oxidation end product of plasma albumin 'in vivo'. Biochem Biophys Res Commun 349 (2006) 668-673
28. Candiano G., Santucci L., Petretto A., et al. High-resolution 2-DE for resolving proteins, protein adducts and complexes in plasma. Electrophoresis 29 (2008) 682-694
29. Gudehithlu K.P., Pegoraro A.A., Dunea G., Arruda J.A., and Singh A.K. Degradation of albumin by the renal proximal tubule cells and the subsequent fate of its fragments. Kidney Int 65 (2004) 2113-2122
30. Comper W.D., Hilliard L.M., Nikolic-Paterson D.J., and Russo L.M. Disease-dependent mechanisms of albuminuria. An invited review. Am J Physiol Renal Physiol 295 (2008) F1589-F1600
31. Tirumalai R.S., Chan K.C., Prieto D.A., Issaq H.J., Conrads T.P., and Veenstra T.D. Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2 (2003) 1096-1103
32. Birn H., and Christensen E.I. Renal albumin absorption in physiology and pathology. Kidney Int 69 (2006) 440-449
33. Vay D., Parodi M., Rolla R., et al. Circulating antibodies recognizing malondialdehyde-modified proteins in healthy subjects. Free Radic Biol Med 30 (2001) 277-286
34. Ishii T., Ito S., Kumazawa S., et al. Site-specific modification of positively-charged surfaces on human serum albumin by malondialdehyde. Biochem Biophys Res Commun 371 (2008) 28-32
35. Ahmed N., Dobler D., Dean M., and Thornalley P.J. Peptide mapping identifies hotspot site of modification in human serum albumin by methylglyoxal involved in ligand binding and esterase activity. J Biol Chem 280 (2005) 5724-5732
36. Cohen M.P., Ziyadeh F.N., and Chen S. Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications. J Lab Clin Med 147 (2006) 211-219
37. Ziyadeh F.N., and Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 4 (2008) 39-45